Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-12-05
2006-12-05
Tate, Christopher R. (Department: 1655)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S757000, C424S641000
Reexamination Certificate
active
07144865
ABSTRACT:
The present invention relates to dietary supplementing methods useful for controlling obesity. More particularly, the invention relates to methods of administration of compositions containing defined chemical species useful for prevention and treatment of obesity. In a preferred embodiment, pharmaceutical compositions used in connection with the present invention comprise: (1) a zinc salt, (2) cyclo-Hispro and/or (3) arachidonic acid, and (4) at least one pharmaceutically acceptable excipient. More particularly, the invention relates to methods of manufacturing of preparing a soybean protein hydrolysate (SPH) comprising cyclo-Hispro.
REFERENCES:
patent: 4273763 (1981-06-01), Horrobin
patent: 5411748 (1995-05-01), Song
patent: 5418218 (1995-05-01), Wilber
patent: 5834032 (1998-11-01), Song
patent: 5904926 (1999-05-01), Slavin
patent: 5989574 (1999-11-01), Slavin
patent: 5997908 (1999-12-01), Song
Russo et al. Hypertension. 1997. vol. 29, No. 4, pp. 1058-1063, MEDLINE Abstract enclosed.
Eder et al. J. Nutritional Biochem. 1997. vol. 8, No. 8, pp. 461-468, EMBASE Abstract enclosed.
Effect of arachidonic acid plus zinc on glucose disposal in genetically diabetic(ob/ob)mice, I.K. Hwang et al.,Diabetes, Obesity and Metabolism, Apr. 2002, pp. 124-131.
Antidiabetic Actions of Arachidonic Acid and Zinc in Genetically Diabetic Goto-Kakizaki Rats, Moon K. Song et al.,Metabolism, vol. 52, No. 1 (Jan.), 2003; pp. 7-12.
Synergistic Antidiabetic Activities of Zinc, Cyclo(His-Pro),and Arachidonic Acid, Moon K. Song et al.,Metabolism, vol. 50, No. 1 (Jan.), 2001; pp. 53-59.
Animal Prostate Extract Ameliorates Diabetic Symptoms by Stimulating Intestinal Zinc Absorption in Rats, M.K. Song et al.,Diabetes Research(1996), 31: pp. 157-170.
Metabolism of Glucose by Rat Pancreatic Islets and Kidney: Comparison of Membrane Preparations with Intact Tissue, Moon K. Song et al.,Pancreas, vol. 24, No. 2, 2002, pp. 205-209.
Effects of Bovine Prostate Powder on Zinc, Glucose, and Insulin Metabolism in Old Patients with Non-Insulin-Dependent Diabetes Mellitus, M.K. Song et al.,Metabolism, vol. 47, No. 1 (Jan. ), 1998, pp. 39-43.
Effects of arachidonic acid and cyclo (his-pro) on zinc transport across small intestine and muscle tissues; M.J. Rosenthal et al.,Life Sciences70 (2001) 337-348.
Anti-Hyperglycemic Activity of Zinc Plus Cyclo(His-Pro)in Genetically Diabetic Goto-Kakizaki and Aged Rats, Moon K. Song et al.,Control of Diabetes by Cyclo(His-Pro), pp. 1338-1345, 2003.
Effects of cyclo(his-pro)plus zinc on glucose metabolism in genetically diabetic obese mice, I.K. Hwang et al.,Diabetes, Obesity and Metabolism, May 2003, pp. 317-324.
Knobbe Martens Olson & Bear LLP
Tate Christopher R.
The United States of America as represented by the Department of
LandOfFree
Compositions and methods for treating obesity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating obesity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating obesity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3654322